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ABSTRACT 
 
Acid-base balance is critical for normal life. Acute and chronic disturbances impact on 
cellular energy metabolism, endocrine signaling, ion channel activity, neuronal activity, 
and cardiovascular functions such as cardiac contractility and vascular blood flow. 
Maintenance and adaptation of acid-base homeostasis are mostly controlled by 
respiration and kidney. The kidney contributes to acid-base balance by reabsorbing 
filtered bicarbonate, regenerating bicarbonate through ammoniagenesis and 
generation of protons, and by excreting acid. This review focuses on acid-base 
disorders caused by renal processes, both inherited and acquired. Distinct rare 
inherited monogenic diseases affecting acid-base handling in the proximal tubule and 
collecting duct have been identified. In the proximal tubule, mutations of SLC4A4 
(electrogenic Na+/HCO3--cotransporter NBCe1) and other genes like CLCN5 (Cl-/H+-
antiporter), SLC2A2 (GLUT2 glucose transporter) or EHHADH (enoyl-CoA, 
hydratase/3-hydroxyacyl CoA dehydrogenase) causing more generalized proximal 
tubule dysfunction can cause proximal renal tubular acidosis due to bicarbonate 
wasting and reduced ammoniagenesis. Mutations in ATP6V1 (B1 H+-ATPase subunit), 
ATPV0A4 (a4 H+-ATPase subunit), SLC4A1 (anion exchanger 1) and FOXI1 (forkhead 
transcription factor) cause distal renal tubular acidosis (dRTA type I). Carbonic 
anhydrase II (CAII) mutations affect several nephron segments and give rise to a mixed 
proximal and distal phenotype. Last, mutations in genes affecting aldosterone 
synthesis, signaling or downstream targets can lead to hyperkalemic variants of renal 
tubular acidosis (type IV). More common forms of renal acidosis are found in patients 
with advanced stages of chronic kidney disease and are, at least in part, due to a 
reduced capacity for ammoniagenesis. 
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Importance to maintain acid-base homeostasis 
 Acid-base homeostasis is critical for normal life. Both acute or chronic 
disturbances can have major impact on normal cellular and organ function and severe 
derangements can eventually lead to death. Acidosis alters ion channel function, 
neuronal excitability with reduced activity, cardiac arrhythmias, decreased cardiac 
contractility which together with vascular relaxation can cause hypotension. Acidosis 
impacts on metabolism by inducing insulin resistance, it inhibits glycolysis and induces 
resistance to catecholamines 1,2. Chronic acidosis causes muscle wasting, contributes 
to development or exacerbation of bone disease, increases inflammation, and plays a 
role in the progression of CKD 3,4. Alkalosis induces vasoconstriction with cardiac 
arrhythmias, confusion, and seizures from arteriolar vasoconstriction with decreased 
cerebral or myocardial perfusion and an increased affinity for O2 to 
hemoglobin/reduced release of O2 from hemoglobin. High pH also increases binding 
of ionized calcium to albumin 5. 
 
Coordinated regulation of acid-base homeostasis 
 Due to its vital importance, several mechanisms exist and cooperate to maintain 
and regulate systemic acid-base balance. Respiration contributes to acute and chronic 
acid-base balance by responding to changes in pH and/or pCO2. Respiration adapts 
within minutes when pH or pCO2 change 6-8. Kidneys respond with a lag time of 2-4 
hours with increased urinary acidification and acid excretion when facing an acid load 
6. Increased renal ammoniagenesis depends on sufficient supply of glutamine that in 
part is shuttled from liver and skeletal muscle contributing to muscle wasting in chronic 
acidosis 3,4. Chronic acidosis may also impact on bone stability as bone is a reservoir 
for bicarbonate and phosphate and low pH can stimulate osteoclast activity 9.  
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Renal processes required for normal acid-base balance 
The kidneys play a central role in the long-term maintenance of acid-base 
homeostasis. The excretion of acid and the regeneration of approximately 1 mmol 
bicarbonate per kg bodyweight per day (e.g. 70 mmoles in an average person of 70 kg 
body weight per day) are critical tasks.  
Maintenance and control of systemic acid-base balance by the kidney is based 
on three major processes: 1) the reclamation of filtered bicarbonate, 2) the excretion 
of acid mostly as ammonium and titratable acidity, and 3) the de novo synthesis of 
bicarbonate replacing bicarbonate used by metabolism 10.  
The kidneys filter about 180 litres/day of primary urine containing an 
approximately 4500 mEq bicarbonate which in a healthy person in steady-state and 
with an average mixed diet is completely reabsorbed along the nephron. About 80% of 
the filtered bicarbonate is reabsorbed in the proximal tubule. In the first step protons 
are secreted by NHE sodium-proton exchangers (mostly the NHE3/SLC9A3 isoform) 
and proton pumps (H+-ATPases). The luminal activity of carbonic anhydrases 
(Carbonic anhydrase type IV (CAIV)) facilitates the formation of CO2 and H2O from 
filtered HCO3- and secreted H+. Then, CO2 and H2O diffuse into proximal tubule cells 
where this process is reversed by type II cytosolic carbonic anhydrase (CAII). The 
produced HCO3- is released into blood via the basolaterally located sodium-
bicarbonate cotransporter (NBCe1/SLC4A4) whereas protons can be recycled into 
urine across the luminal membrane (Figure 1). Recently an additional mechanism of 
proximal tubule bicarbonate reabsorption was suggested: reabsorption via an apically 
located sodium-dependent bicarbonate cotransporter (NBCn2) 11. The significance of 
this transporter remains to be established. Moreover, a fraction of bicarbonate is 
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reabsorbed through the paracellular pathway in the proximal tubule driven by the 
luminal accumulation of chloride and the resulting lumen-negative potential.  
The remaining bicarbonate (approx. 20 % of the filtered load) is subsequently 
reabsorbed along the thick ascending limb of the loop of Henle by transcellular 
mechanisms similar to the proximal tubule involving NHE exchangers and to a lesser 
extent H+-ATPases on the luminal side and a Cl-/HCO3--exchanger at the basolateral 
side 12-14. 
Metabolic processes consume bicarbonate (i.e. in the urea cycle) and produce 
acids (i.e. in amino acid metabolism) that must be buffered by bicarbonate. The kidney 
replenishes bicarbonate by de novo generation of bicarbonate during proximal tubular 
ammoniagenesis and by hydration of CO2 in acid-secretory type A intercalated cells. 
Ammoniagenesis occurs in the proximal tubule through a series of enzymatic reactions 
located partially in the mitochondria and partially in the cytosol (Figure 2, upper 
panel). Glutamine is the primary fuel for ammoniagenesis and is mostly extracted from 
peritubular blood vessels. Glutamine is also absorbed from primary urine but since 
glutamine reabsorption is nearly 100 % of the filtered load, increased demand for 
glutamine during acidosis cannot be met and basolateral glutamine uptake is 
upregulated during acidosis. The transporter(s) mediating basolateral glutamine 
uptake have not been fully identified. The SNAT3 (SLC38A3) glutamine transporter is 
located basolaterally in the proximal tubule and its expression is enhanced during 
metabolic acidosis or hypokalemia, conditions stimulating ammoniagenesis and 
glutamine extraction 15-18. Moreover, a mouse model with complete lack of Snat3 
expression dies early but shows signs of reduced ammoniagenesis 19. In contrast, a 
more recent study in mice deficient for the transcription factor Nrf2 showed that 
expression and regulation of Snat3 in kidney is greatly reduced in the absence of Nrf2 
but that Nrf2 KO mice retain the full capacity to stimulate ammoniagenesis and urinary 
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ammonium excretion 20. Thus, SNAT3 is likely not the only glutamine importing 
transporter. The amino acid exchanger LAT2 may also contribute. 
Urinary ammonium excretion is a process involving several steps. In the 
proximal tubule, a fraction of ammonium is transferred into urine (another fraction is 
also released back into circulation). Then ammonium is mostly reabsorbed by the 
Na/K/2Cl-cotransporter NKCC2 in the thick ascending limb of the loop of Henle, 
accumulates in the (medullary) interstitium and is finally actively secreted by the cells 
lining the collecting duct system into urine in the form of ammonia (see below) (Figure 
2, lower panel). Accumulation in the medullary interstitium requires also the NHE4 
Na+/H+-exchanger (SLC9A4), the NBCn1 electroneutral Na+/HCO3--cotransporter 
(SLC4A7) and sulfatides 21-23. 
Final urinary acidification and fine-tuning of renal acid-excretion is mediated by 
the collecting system consisting of the connecting tubule, the cortical and medullary 
parts of the collecting duct 24. However, the first intercalated cells appear already in the 
late distal convoluted tubule 25. At least two distinct subtypes of intercalated exist: type 
A intercalated cells and non-type A intercalated cells. The latter may exist in two 
different forms, as type B intercalated cells and as non-A/non-B intercalated cells. 
Whether these forms are only distinct states of the same cell type or represent two 
truly different cells has not been clarified up to date.  
Acid-secretory type A intercalated cells mediate ammonia excretion into urine 
as well as urinary acidification coupled to de novo synthesis of bicarbonate (Figure 3). 
CO2 hydration is facilitated by cytosolic carbonic anhydrase II (CAII) forming protons 
and bicarbonate 10. Bicarbonate is released into blood via the basolaterally located 
chloride-bicarbonate exchanger AE1 (Anion exchanger 1, SLC4A1) whereas protons 
are secreted into urine by vacuolar-type H+-ATPase pumps at the luminal membrane 
24,26. As discussed below, genetic mutations in SLC4A1 or two different subunits of the 
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multimeric H+-ATPase (consisting of more than 14 subunits with multiple isoforms) 
cause inherited forms of distal renal tubular acidosis (dRTA) 27-29; The secretion of 
protons into urine acidifies urine to a maximal pH of approximately 4.5 - 4.0. Stronger 
acidification of urine is impossible as H+-ATPases must pump against a steep proton 
gradient (intracellular pH 7.2, luminal pH 4.5). Eventually, one liter of unbuffered urine 
of pH 4.5 contains about 30 µmoles protons, a negligible amount compared to the 
requirement to excrete 70 mmoles of acid. Several urinary buffers, so-called titratable 
acidity (the term refers to the method to measure titratable acidity by back-titrating 
acidified urine), buffer protons and thereby enhance the amount of excretable acid. 
The main “titratable acid» is phosphate, but creatinine and urate also contribute to 
variable extents. The sum of urinary ammonium plus titratable acidity minus 
bicarbonate is called net acid secretion. For the sake of simplicity, urinary phosphate 
can be taken as approximation for titratable acidity and urinary bicarbonate can be 
neglected when urine pH is below pH 6.5 [8].  
Proton and ammonia secretion is coupled where luminal ammonia (NH3) 
captures free protons and is trapped in urine in the form of ammonium (NH4+). 
Ammonia secretion by intercalated cells (and also by neighboring principal cells) is 
mediated by two related gas channels belonging to the family of the rhesus blood group 
proteins, namely RhBG and RhCG (Figure 3) 30-32. RhBG is exclusively located at the 
basolateral membrane whereas RhCG is the only known apical transport pathway for 
ammonia 31,33. RhCG is also found at the basolateral membrane where it also 
contributes to ammonia uptake from interstitium 31. Rhcg and Rhbg are upregulated 
during acidosis in mice 34. On the contrary, lack of Rhcg causes a form of dRTA in mice 
characterized by the inability to excrete ammonium 30,31,35,36. The role of RhBG is less 
clear as a mild defect has been reported in one knockout mouse line but not in another 
37-39. Absence of Rhcg in mice is also associated with a mild defect in the capacity to 
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maximally acidify urine which may be caused by the stimulatory interaction of Rhcg 
with H+-ATPases 40. Intronic single nucleotide polymorphisms in RhCG have been 
associated with 24-hrs urinary pH but no mutations have been linked to human dRTA 
up to date 41. The activity of type A intercalated cells and net acid secretion is 
stimulated during acidosis and reduced during alkalosis 10. 
Type B intercalated cells are located in the distal convoluted tubule, connecting 
tubule and cortical collecting duct 25. Only few type B intercalated cells are found in the 
initial part of the outer medullary collecting duct but are absent from the inner part of 
the outer medullary collecting duct and from the inner medullary collecting duct 25. 
These cells express the chloride/bicarbonate exchanger pendrin (SLC26A4) on their 
luminal membrane, cytosolic carbonic anhydrase II, and H+-ATPases on their 
basolateral membrane. Their main function is the secretion of bicarbonate to 
compensate for alkalemic states 42,43. Non-type A/non-type B intercalated cells are 
characterized by the luminal appearance of pendrin and the colocalization of H+-
ATPases at the same membrane (and sometimes also additional H+-ATPases at the 
basolateral membrane). Thus, in this cell type bicarbonate secretion by pendrin is 
paralleled by H+-ATPase mediated proton secretion resulting in net chloride absorption 
42,44. Moreover, type B intercalated cells may play an important role in NaCl 
homeostasis by contributing to chloride absorption involving pendrin and the Na+-
dependent Cl-/HCO3--exchanger 45-51. 
 
Inherited disorders of renal acid-base handling 
 Inherited disorders of renal acid-base handling are considered to be rare. 
Whether common polymorphisms or milder mutations may contribute to forms of 
incomplete dRTA and may predispose to nephrolithiasis or –calcinosis is not well 
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established. However, variants in some genes discussed below have been found in 
families with stone disease 52,53. Clearly, larger and more detailed studies are 
warranted to elucidate the relevance of common variants.  
 
Gene defects underlying proximal renal tubular acidosis (pRTA, type II RTA) 
 kNBCe1 (SLC4A4) 
 Pathogenic mutations in the SLC4A4 gene encoding for the basolateral 
electrogenic sodium-bicarbonate cotransporter NBCe1 cause proximal renal  tubular 
acidosis with ocular abnormalities and mental retardation (OMIM #604278, table 1) 
54,55. Patients often present with growth retardation and short stature, metabolic 
acidosis with low bicarbonate, mental retardation, teeth enamel defects, and bilateral 
glaucoma, cataracts, and band keratopathy 56. Since proximal tubular bicarbonate 
transport is impaired the threshold for bicarbonate reabsorption is reduced and can be 
tested using an alkali-loading test restoring plasma bicarbonate levels to normal. 
Urinary acidification and ammoniagenesis are intact and due to metabolic acidosis will 
be maximized 57. Other functions of the proximal tubule such as glucose, phosphate, 
or amino acid reabsorption are not primarily affected. Mutations identified are mostly 
missense mutations that affect trafficking of mutant transporters to the membrane 
and/or alter function of the transporter, e.g. reduced activity or inducing anion leaks 
55,58,59. 
 Activity of NBCe1 is thought to be closely coupled to apical Na+/H+-exchanger 
activity, mostly mediated by the NHE3 isoform (SLC9A3 gene). Recently, several 
families with SLC9A3 mutations were identified for suffering from chloride diarrhea but 
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no renal or acid-base related phenotype was reported 60. Mice with deletion of Slc9a3 
are acidotic and show greatly reduced proximal tubule bicarbonate reabsorption 61. 
 Fanconi-syndrome 
 pRTA can be part of a generalized dysfunction of the proximal tubule known as 
De-Toni-Debré-Fanconi syndrome. Patients suffer from urinary loss of various 
substrates typically reabsorbed by the proximal tubule including bicarbonate, amino 
acids, glucose, low molecular weight protein, and phosphate. This syndrome can be 
acquired, e.g. due to drug toxicity or light chain disease 62,63, or inherited due to 
mutations in genes affecting overall proximal tubule function 64. Various monogenic 
causes have been identified to underlie forms of the De-Toni-Debré-Fanconi syndrome 
including CLCN5 and ORCL (Dent's disease I and II), cystosin (CTNS) in cystonosis, 
ATP7B in Wilson disease, Fumarylacetoacetate hydrolase (FAH), Tyrosine 
aminotransferase (TAT) and 4-hydroxyphenylpyruvate dioxygenase (HPD) in 
tyrosinemia type I-III, and Galactose-1-phosphate uridylyl-transferase (GALT) in 
galactosemia  (table 1).  
 
Gene defects underlying distal renal tubular acidosis (dRTA, type I RTA) 
 Typical dRTA is characterized by the inability to acidify urine below pH 
5.3 in the presence of metabolic acidosis. Urinary excretion of ammonium and titratable 
acids is also decreased causing an overall reduction in urinary acid excretion 10. 
Patients present with hyperchloremic metabolic acidosis with normal anion gap often 
associated with hypokalemia. Failure to thrive, growth retardation, rickets, and 
nephrolithiasis or nephrocalcinosis may occur during childhood and adolescence and 
often lead to the initial diagnosis. Some patients also develop polyuria which may be 
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triggered by the reduced capacity to concentrate urine because of hypercalciuria, 
hypokalemia or nephrocalcinosis 49,65,66.  Mutations in at least 4 different genes can 
cause distal renal tubular acidosis (dRTA) in humans: SLC4A1, ATP6V0A4, 
ATP6V1B1, FOXI1 (table 1). Likely mutations in additional genes contribute to the 
pathogenesis of dRTA as about 20-30 % of patients with inherited forms of dRTA have 
no mutations in the coding regions of these 4 genes. Additionally, mutations in non-
coding regions of these known genes such as in the promoter region may also cause 
dRTA but this has not been systematically addressed to date. 
  
 SLC4A1 (AE1) 
 SLC4A1 encodes for the chloride-bicarbonate exchanger Anion Exchanger 1 
(AE1), in kidney specifically expressed in type A intercalated cells. Two transcripts 
exist with a longer transcript encoding for the erythroid AE1 variant whereas a shorter 
transcript encodes for the renal variant that lacks the first 65 amino acids. Mutations in 
SLC4A1 are repsonsible either dRTA or red blood cell abnormalities including 
spherocytosis or South-East Asian ovalocytosis (SAO). Most mutations cause either 
dRTA or hematological abnormalities but only few mutations are associated with both 
diseases. Inheritance is usually autosomal dominant but few autosomal recessive 
mutations have been described. The most frequent recessive mutation, G701D, 
causes dRTA that can be associated with hemolytic anemia. AE1 interacts with the 
chaperone glycophorin which is only expressed in red blood cells and is able to rescue 
"renal" mutations bringing them to the red blood cell membrane 67. A series of 
additional mutations has been identified that are more common in South-East Asia and 
are frequently associated with a red blood cell phenotype. It has been hypothesized 
that some of these mutations may confer resistance to malaria 68. In contrast to the 
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recessive mutations, patients with a Caucasian background carry more frequently 
dominant mutations, the R589H being the most common one, that rather causes dRTA 
69,70. Several classes of AE1 mutations have been identified that may cause either 
intracellular retention of mutant AE1 or even mistargeting to the luminal membrane of 
intercalated cell models 71-73. In mice, the complete absence of AE1 causes severe 
metabolic acidosis and reduced renal acid excretion 74. Introduction of the R607H 
mutation in mice (corresponds to human R589H) impairs intercalated cell function and 
reduces expression of proton pumps 69. 
  
 ATP6V1B1 (B1 H+-ATPase) and ATP6V0A4 (a4 H+-ATPase) 
 Mutations in the genes encoding for the B1 (ATP6V1B1) and a4 (ATP6V0A4) 
H+-ATPase subunits cause dRTA 28,75. The H+-ATPase proton pump is a multimeric 
protein complex with two major domains, the cytosolic catalytic V1-domain hydrolyzing 
ATP (with 8 subunits A-H) and the membrane-bound V0-domain mediating proton 
transfer with the a, c, c“, d, and e subunits 76. The B1 subunit is part of the V1-domain 
whereas the a4 subunit belongs to the V0-domain (Figure 4). The B1 subunit is 
selectively expressed in kidney, inner ear, epididymis and lung. In kidney, the B1 
subunit is highly enriched in all subtypes of intercalated cells but is also found at lower 
levels in the thick ascending limb of Henle. Similarly, the a4 subunit is also enriched in 
all types of intercalated cells but is also highly abundant in the proximal tubule and in 
the thick ascending limb of the loop of Henle 77. The subunit is also expressed in 
epididymis and the stria vascularis of the inner ear 75,78. The expression of both subunit 
isoforms, B1 and a4, in the inner ear explains the occurrence of sensorineural deafness 
in patients with mutations in these subunits. However, the progression of sensorineural 
deafness is variable in patients and is not responsive to alkali therapy 79,80. Some 
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patients also develop dizziness likely secondary to an enlarged vestibular aqueduct 
(EVA) 80. Whether male fertility is altered due to alterations in proton pump function in 
the epididymis has not been examined. 
Experiments in yeast and cell culture models demonstrated that most of the B1 
subunit mutations cause either dysfunction or impaired assembly of the protein 
complex 81,82. Mice deficient for the B1 subunit have a reduced capacity to acidify urine 
and develop more severe metabolic acidosis when acid-challenged. When bred with 
hypercalciuric mice, B1 knockout mice develop severe nephrocalcinosis with 
hydronephrosis 65,83,84. Also, proton pumps lacking the B1 subunit do not respond to 
stimulation by angiotensin II 84. 
Deletion of the a4 subunit in mice leads to severe dRTA with hypokalemia, 
nephrocalcinosis, and lower bone mineral density 85,86. a4 knockout mice develop also 
massive hearing loss and a reduced sense of smell. The a4 subunit is also expressed 
in the proximal tubule and its absence is associated with low molecular weight 
proteinuria demonstrating an important role of this subunit in receptor-mediated 
endocytosis 86. In one series of patients with mutations in either ATP6V1B1 or 
ATP6V0A4, mutations in the latter were associated with a more severe clinical 
presentation and reduced kidney function 86. However, another series did not find a 
clear association between mutations in ATP6V1B1, ATP6V0A4, or SLC4A1 and 
progression to CKD 70. Of note, many patients had signs of a Fanconi-syndrome at 
initial presentation which ceased upon alkali therapy 70.  
 
 FOXI1 
More recently, missense mutations in the forkhead transcription factor FOXI1 were 
identified in two families with hyperchloremic non-anion gap dRTA and sensorineural 
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deafness 87. Mutations identified are missense mutations that impair the ability of 
FOXI1 to activate its target genes whereas translocation into the nucleus appeared to 
be intact. In kidney, transcriptional targets of FOXI1 are the AE1 and AE4 anion 
exchangers, and the A, B1, E2 and a4 subunits of the H+-ATPase 88-90. Deletion of 
Foxi1 in mice causes dRTA with deafness and infertility in male mice. FOXI1 is 
expressed in mouse kidney, in the epithelium of the endolymphatic duct and sac 
epithelium of the inner ear 88-90. In mouse kidney, absence of Foxi1 causes loss of 
differentiation of the different cell types in the collecting duct giving rise to 
undifferentiated cell type coexpressing markers of principal and intercalated cells 89. 
Likewise, in Xenopus frog skin, the formation of mitochondria-rich proton-secreting 
cells (resembling collecting duct intercalated cells) depends on FOXI1 activity 91.  
WDR72 
Mutations in WDR72 have been identiﬁed in a few fami-lies with amelogenesis 
imperfecta, a disease reducing min-eralization of teeth. Some of the affected 
individuals   were  also  tested  for  renal  function  and  had  metabolic acidosis and 
impaired urinary acidiﬁcation suggesting the presence of dRTA. Mutations in WDR72 
appear to be inherited in an autosomal recessive manner. The hearing status of 
affected patients is unknown. Single cell transcriptome data from mouse kidney 
suggest a high enrichment of Wdr72 in the collecting duct but the exact function of the 
protein is currently unknown. Of note, GWAS linked WDR72 to urinary pH and risk for 
lower eGFR 92-95. 
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 Further genes 
 Not all cases of inherited dRTA can be explained by mutations in the coding 
region of the genes discussed above suggesting that additional mutations may lie in 
the non-coding region, e.g. promoter region, or that mutations in additional genes may 
contribute to inherited dRTA. Candidate genes include the K+/Cl--cotransporter KCC4 
(SLC12A7) 96, the Cl-/HCO3- -exchanger SLC26A7 97, the ammonia channels RhBG 
and RhCG (SLC42A2, SLC42A3) 30, the hensin (DMBT1)-CXCL12 signal complex 
98,99, or other H+-ATPase subunits 100.  
 
Gene defects with mixed proximal and distal renal tubular acidosis 
 Mixed RTA with features of proximal and distal defects in bicarbonate 
reabsorption and urinary acid excretion is seen in patients with mutations in carbonic 
anhydrase II 101 (table 1). In addition, patients suffer from osteopetrosis and mental 
retardation due to functions of CAII in bone and brain. The combined renal defect is 
explained by the central role of CAII in proximal bicarbonate transport and distal 
generation of H+ and HCO3- (see figures 1 and 3).  
 
Gene defects causing hyperkalemic dRTA (type IV dRTA) 
 Hyperkalemic dRTA is caused by gene defects in the pathways underlying 
aldosterone synthesis, signaling or its targets (table 1). Aldosterone is involved in 
regulating collecting duct acid-base transport 10,102 and is critical to maintain 
normokalemia 103,104. Hyperkalemia as a consequence of aldosterone deficiency by 
itself may suppress ammoniagenesis and urinary acidification 102,105.  
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 Inactivating mutations of 11-beta-hydroxylase (aldosterone synthase) reduce 
aldosterone levels whereas loss-of-function mutations in the mineralocorticoid receptor 
(NR3C2) impair aldosterone signaling 106,107.  In contrast, mutations in the three 
subunits of the epithelial Na+-channel (ENaC) can underlie forms of 
pseudohypoaldosteronism with renal salt loss, hyperkalemia, and acidosis (table 1). 
Also mutations in WNK1 and WNK4 as well as in Kelch-like3 (KLHL3) and Cullin 
(CUL3), regulators of WNK expression and activity, stimulate activity of the Na+/Cl- -
cotransporter NCC causing hypertension, hyperkalemia and metabolic acidosis 108. 
Acidosis in these patients is likely mostly a consequence of impaired renal K+-excretion 
secondary to NCC overactivity, alternatively, overactivation of pendrin-mediated 
bicarbonate secretion has been suggested as major mechanism 109. 
  
Gene defects associated with alkalosis 
 Several tubulopathies can be associated with secondary alkalosis such as in 
patients with Bartter syndrome where alkalosis is thought to be the consequence of 
the adaptive upregulation of proximal tubular transport pathways in response to volume 
contraction 110. Mutations in pendrin (SLC26A4) underlie Pendred syndrome 
characterized by sensorineural deafness, goiter and hypothyrodism 111. As discussed 
earlier, pendrin is involved in the renal defence mechanisms against alkalosis and 
involved in chloride reabsorption. Whether absence of pendrin predisposes or even 
causes metabolic alkalosis in humans has remained an open question. A case report 
from a patient with Pendred syndrome and liver disease and an episode of prolonged 
vomiting demonstrated severe alkalosis 112. 
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Acquired inability of renal acid excretion 
 CKD 
 Metabolic acidosis is found in a majority of patients with advanced stages of 
CKD and a GFR below 20 - 30 ml/min. Plasma bicarbonate levels are reduced to 12-
22 mM 113. Besides the problems associated with chronic metabolic acidosis such as 
loss of bone density and muscle wasting, metabolic acidosis itself may promote 
progression of kidney disease as indicated both from animal studies as well as from 
recent interventional studies demonstrating the beneficial effect of alkalinizing 
therapies on further loss of kidney function 114-118. The capacity to maximally acidify 
urine is preserved in these patients whereas the excretion of ammonium is reduced 
and clearly inappropriate considering the degree of metabolic acidosis 113. Studies in 
rodent models suggest that progression of kidney disease causes reduced expression 
of enzymes and transporters involved in ammoniagenesis and ammonium excretion 
119,120. Whether only reduced nephron mass or specific dysregulation of components 
of the ammoniagenic pathway and acid-excretory proteins are responsible for reduced 
ammonium excretion requires final clarification. 
 
 Sjögren's syndrome 
 Sjögren syndrome is an autoimmune disorder that can affect in about 30 % of 
patients also renal functions and cause hypokalemic non-anion gap hyperchloremic 
acidosis with impaired distal renal tubular acidification 121-123. In a few patients, 
autoantibodies cross-reacting with intercalated cells have been reported suggesting 
that antibody-mediated events may impair intercalated cell function 124. In an 
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unpublished small series of histological analyses of kidneys from patients with 
Sjögrens syndrome and dRTA we did not detect any staining for markers of type A 
intercalated cells suggesting that these cells are either absent or severely impaired 
(Mohebbi, Walsh, Devuyst, Unwin, Ronco, Wagner, unpublished data). Likewise, 
absence of H+-ATPase and/or AE1 staining in kidneys from patients with Sjögren's 
syndrome had been previously reported 73,122. Also, a case of patient with hypokalemic 
dRTA with autoimmune atrophic gastritis and hypothyroidism, autoantibodies were 
detected reacting with intercalated cells but the antigen(s) have remained unknown 125. 
Moreover, the kidney biopsy from the patients had no detectable type A intercalated 
cells which may explain the severe dRTA 125.   
Outlook 
Our understanding of the molecular and cellular mechanisms underlying the kidneys 
ability to maintain and regulate acid-base balance have advanced much over the past 
decades. Identification of genes mutated in human disorders of acid-base homeostasis 
together with the rise of transgenic mouse models have been instrumental to 
demonstrate the identity and relevance of various pathways. Nevertheless, gaps in our 
understanding remain and only a few are briefly mentioned here. First, one complex of 
questions relates to the identity and function of sensors of acid-base status. Several 
molecules have been identified that can sense changes in intra- and/or extracellular 
concentrations of protons or bicarbonate including the G protein-coupled receptors 
OGR1, GPR4 and TDAG8 7,126,127, the tyrosine receptor kinase Insulin-receptor-related 
receptor (IRRR) and the receptor-type protein tyrosine phosphatase gamma 
(RPTPγ)128 , the soluble adenylyl cyclase (sAC)129,130, or the tyrosine kinase Pyk2 
131,132. Even though it is likely that an essential function such as pH-sensing and 
regulation does not entirely depend on a single pathway, none of these pathways 
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seems to play a critical role for the kidneys function in acid-base homeostasis. Clearly, 
the relative relevance and physiological function of these pathways and molecules has 
only started to emerge. Second, the interplay of various organs in regulating acid-base 
balance may deserve more attention. How is the function of organs such as brain, 
kidney, liver, muscle and bone coordinated ? Are systemic changes in pH sufficient to 
trigger coordinated responses ? Which other signals are involved ? Third, while a 
majority of patient cases of pRTA and dRTA can be explained based on identifiable 
gene mutations, a substantial number of patients with inherited forms of RTA remains 
with unknown underlying genetic defect(s). One can expect that full genome 
sequencing together with functional studies on mutated candidate genes will solve 
many of these cases. Fourth, in acquired syndromes of RTA (i.e. in CKD, Sjögren's 
syndrome), the cellular and molecular mechanisms have only partly been addressed. 
While loss of nephron mass plays an important role in reduced ammoniagenesis in 
CKD, the role of inflammation has not been examined in much detail. Fifth, the impact 
of acidosis on progression of CKD is an interesting question with a high clinical 
potential. While several clinical trials are on-going and aim to provide further evidence 
for the therapeutic potential of alkali supplementation, the underlying mechanisms how 
acidosis accelerates progression of CKD remain to be further defined. Elucidation of 
molecular mechanisms may yield novel therapeutic targets. Last, acid-base 
homeostasis and systemic as well as local inflammation is a mostly unchartered area. 
The association of local inflammation and hypoxia and acidosis is well documented 
and acidic pH is involved in recruiting and /or activating inflammatory cells. Whether 
similar processes are operative during systemic acidosis is not well studied but has 
major implications for advanced stages of CKD and possibly also for patients with 
inherited forms of RTA. 
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Figure legends 
 
Table 1: Molecular genetics of renal tubular acidosis 
Summary of genes with known mutations causing distinct forms of renal tubular 
acidosis. AR autosomal recessive, AD autosomal dominant, XLR X-linked recessive 
 
Figure 1: Proximal mechanisms of bicarbonate transport 
Reabsorption of bicarbonate in the proximal tubule is initiated by active proton 
secretion via the luminal Na+/H+-exchanger NHE3 and H+-ATPases. Protons and 
bicarbonate react to form CO2 and H2O, catalyzed by membane-bound carbonic 
anhydrase IV (CAIV). CO2 diffuses into proximal tubular cells and is hydrated facilitated 
by cytosolic carbonic anhydrase II (CAII) to yield HCO3- and H+. Whereas H+ can 
recycle across the luminal membrane, HCO3- is transported to blood by the basolateral 
Na+/HCO3--cotransporter NBCe1. Some luminal HCO3- may be directly reabsorbed by 
the apically located Na+/HCO3--cotransporter NBCn2. Mutations in NBCe1 can cause 
pRTA, mutations in CAII give rise to a mixed pRTA and dRTA phenotype. 
 
Figure 2: Proximal ammoniagenesis and tubular ammonium handling 
Upper panel: Ammoniagenesis in the proximal tubule. Glutamine is extracted from 
blood involving SNAT3 and LAT2 transporters and converted to α-ketoglutarate by 
mitochondrial phosphate-dependent glutaminase (PDG) and glutamate 
dehydrogenase (GDH) thereby releasing NH3. α-ketoglutarate is the substrate for renal 
gluconeogenesis and NH3 mostly combines with protons to form NH4+ which is 
released into urine. SNAT3: sodium dependent amino acid transporter SLC38A3, 
LAT2 type L amino acid transporter, NHE3: sodium/proton antiporter isoform 3 
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SLC9A3, NBCe1: sodium bicarbonate cotransporter SLC4A4, PDG: phosphate-
dependent glutaminase, GDH: glutamate dehydrogenase, αKG: α-ketoglutarate, TCA: 
tricarboxylic acid (TCA) cycle, PEPCK: phosphoenolpyruvate carboxykinase. 
Lower panel: Ammonium transport along the nephron. NH4+ released into urine in the 
proximal tubule is partly reabsorbed in the thick ascending limb of the loop of Henle 
and accumulated with a cortico-medullary gradient in the interstitium. NH3 is secreted 
into urine along the collecting duct and is ultimately excreted as NH4+. 
 
Figure 3: Acid-base handling by collecting duct intercalated cells, indicate 
mutations 
Schematic of major transport pathways in type A and B intercalated cells. Type A 
intercalated cells (upper panel) secrete H+ via apical H+-ATPases and H+/K+-ATPases 
into urine where they are buffered by either by NH3 or titratable acids (TA). Protons are 
generated from CO2 and H2O catalyzed by cytosolic carbonic anhydrase II (CAII) 
yielding also HCO3- to be released into blood by basolateral Cl-/HCO3--exchanger AE1. 
Type A intercalated cells, together with other collecting duct cells take up NH4+ via 
NKCC1 and Na+/K+-ATPases and NH3 via RhCG and RhBG transporters. NH3 is 
secreted into urine by luminal RhCG transporters. Type B intercalated cells express 
luminally the Cl-/HCO3--exchanger pendrin that either works in parallel with luminal H+-
ATPases to mediate net chloride absorption or works together with basolateral H+-
ATPases to allow for net secretion of HCO3- and absorption of Cl-.   
 
Figure 4: Mutations in intercalated cells causing dRTA 
Mutations in either the SLC4A1 (AE1) transporter or the a4 or B1 isoforms of the H+-
ATPase subunits can cause dRTA. Also mutations in the FOXI1 transcription factor 
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controlling expression of AE1, CAII, and the B1 and a4 H+-ATPase subunits causes 
dRTA. The insert shows a model of the H+-ATPase indicating the localization of the B 
(either B1 or B2) and a (a1-a4 isoforms) subunits. 
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Table 1: Molecular genetics of renal tubular acidosis  
 
Type 
RTA 
Gene Protein Inheritance OMIM1 
Type I     
 SLC4A1 AE1 Cl-/HCO3- anion exchanger 1 AD/AR # 611590 
 ATP6V1B1 B1 H+-ATPase subunit AR # 267300 
 ATP6V0A4 a4 H+-ATPase subunit AR # 602722 
 FOXI1 Forkhead box I1 AR # 6007912 
 WDR72 WDR72 AR # 613211 
Type II     
 SLC4A4 Na+-HCO3--cotransporter NBCe1 AR # 604278 
 CLCN5 Cl-/H+-antiporter XLR # 300009, 
# 10468 
 OCRL Oculocerebrorenal syndrome 
Lowe 
XLR # 309000 
 SLC2A2 GLUT2 AR # 227810 
 CTNS Cystinosin  AR # 219800 
 EHHADH Enoyl-CoA-hydratase:3-
hydroxyacyl-CoA dehydrogenase 
AD # 615605 
 ATP7B Cu2+-ATPase AR # 277900 
 FAH Fumarylacetoacetate hydrolase AR # 276700 
 TAT Tyrosine aminotransferase AR # 276600 
 HPD 4-hydroxyphenylpyruvate 
dioxygenase 
AR/ AD # 276710 
# 140350 
 GALT Galactose-1-phosphate uridylyl-
transferase 
AR # 230400 
Type III     
 CAII Carbonic anhydrase II AR # 259730 
Type IV     
 CYP11B2 11-beta-hydroxylase, aldosterone 
synthase 
AR # 202010 
 NR3C2 Mineralocorticoid receptor AD # 177735 
 SCNN1A α subunit epithelial Na+ channel AR # 264350 
 SCNN1B β subunit epithelial Na+ channel AR # 264350 
 SCNN1G γ subunit epithelial Na+ channel AR # 264350 
 WNK1 With No Lysine kinase 1 AD # 614492 
 WNK4 With No Lysine kinase 4 AD # 614491 
 KLHL3 Kelch-like 3 AD/AR # 614495 
 CUL3 Cullin-3 AD # 614496 
 
 
 
 
                                                          
1 Online Mendelian Inheritance in Man: https://www.omim.org/ 
2 no distinct OMIM number has been assigned to FOXI1 mutations, the number refers to a phenotype 
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